METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination

MLA

Danyang Shen, et al. “METTL14-Mediated Lnc-LSG1 M6A Modification Inhibits Clear Cell Renal Cell Carcinoma Metastasis via Regulating ESRP2 Ubiquitination.” Molecular Therapy: Nucleic Acids, vol. 27, no. 547–561, Mar. 2022, pp. 547–61. EBSCOhost, https://doi.org/10.1016/j.omtn.2021.12.024.

APA

Danyang Shen, Lifeng Ding, Zeyi Lu, Ruyue Wang, Chenhao Yu, Huan Wang, Qiming Zheng, Xuliang Wang, Wanjiang Xu, Haifeng Yu, Liwei Xu, Mingchao Wang, Shicheng Yu, Shibin Zhu, Jun Qian, Liqun Xia, & Gonghui Li. (2022). METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination. Molecular Therapy: Nucleic Acids, 27(547–561), 547–561. https://doi.org/10.1016/j.omtn.2021.12.024

Chicago

Danyang Shen, Lifeng Ding, Zeyi Lu, Ruyue Wang, Chenhao Yu, Huan Wang, Qiming Zheng, et al. 2022. “METTL14-Mediated Lnc-LSG1 M6A Modification Inhibits Clear Cell Renal Cell Carcinoma Metastasis via Regulating ESRP2 Ubiquitination.” Molecular Therapy: Nucleic Acids 27 (547–561): 547–61. doi:10.1016/j.omtn.2021.12.024.